Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Tobias Gedde Dahl"'
Autor:
Yishan Ye, Myriam Labopin, Jia Chen, Depei Wu, Tobias Gedde-Dahl, Didier Blaise, Gérard Socie, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-6 (2024)
Externí odkaz:
https://doaj.org/article/7163a660c08445078506213d07c2c471
Autor:
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Zafer Gülbas, Tobias Gedde-Dahl, Cristina Castilla-Llorente, Nicolaus Kröger, Mathias Eder, Alessandro Rambaldi, Francesca Bonifazi, Igor Wolfgang Blau, Matthias Stelljes, Peter Dreger, Ivan Moiseev, Hélène Schoemans, Christian Koenecke, Zinaida Peric
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract There is an increased risk of GVHD and of non-relapse mortality (NRM) after allogeneic stem cell transplantations (alloSCT) when mismatched unrelated donors (MMUD) are used. In Europe, it is standard practice to use rabbit anti-thymocyte glo
Externí odkaz:
https://doaj.org/article/088862a804d845c78b5a8f61b6c2b139
Autor:
B. Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, Andrea Lenartova, Mats Remberger, Ingerid Weum Abrahamsen, Geir Erland Tjønnfjord, Anders Eivind Myhre, Yngvar Fløisand, Tobias Gedde‐Dahl
Publikováno v:
eJHaem, Vol 5, Iss 1, Pp 117-124 (2024)
Abstract Outcomes of 2‐year survivours undergoing allo‐haematopoietic stem cell transplantation at Oslo University Hospital were retrospectively assessed with the objectives of identification of risk factors for late death as possible means for p
Externí odkaz:
https://doaj.org/article/6f59336744bb49a58d2ca6f2b8867c5f
Autor:
Beatrice Fageräng, Leon Cyranka, Camilla Schjalm, Karin Ekholt McAdam, Carina Sandem Larsen, Julia Heinzelbecker, Tobias Gedde-Dahl, Reinhard Würzner, Terje Espevik, Geir Erland Tjønnfjord, Peter Garred, Andreas Barratt-Due, Tor Henrik Anderson Tvedt, Tom Eirik Mollnes
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionHematopoietic stem cell transplantation (HSCT) is associated with immune complications and endothelial dysfunction due to intricate donor-recipient interactions, conditioning regimens, and inflammatory responses.MethodsThis study investig
Externí odkaz:
https://doaj.org/article/36736c7b93574c8399216af84399d6a5
Autor:
Sabine Blum, Yves Chalandon, Myriam Labopin, Jürgen Finke, Tobias Gedde-Dahl, Tarek Ben Othman, Jan J. Cornelissen, Pavel Jindra, Hélène Labussière-Wallet, Matthew Collin, Stig Lenhoff, Guido Kobbe, Norma C. Gutiérrez, Arnon Nagler, Mohamad Mohty
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/33b53f37a16444f98acbf1e05d2e0edf
Autor:
Joanna Drozd-Sokolowska, Luuk Gras, Linda Koster, Rodrigo Martino, María Queralt Salas, Urpu Salmenniemi, Teresa Zudaire, Lucrecia Yañez, Mar Bellido, Matthew Collin, Martin Kaufmann, Piotr Kozlowski, Xavier Poiré, Christelle Ferra, Antònia Sampol, Keith M. O. Wilson, Anne Cairoli, Tobias Gedde-Dahl, Eric Deconinck, Milena Mirabile, Felipe Suarez, Kavita Raj, Michel van Gelder, Ibrahim Yakoub-Agha, Olivier Tournilhac, Donal P. McLornan
Publikováno v:
Haematologica, Vol 109, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/ad61bf4e936e49b5bf37ef1b596771db
Autor:
George B. McDonald, Ole J.B. Landsverk, Dermot P.B. McGovern, Anders Aasebø, Vemund Paulsen, Talin Haritunians, Henrik M. Reims, Bernadette M. McLaughlin, Timothy Zisman, Dalin Li, Elisabeth T.M.M. Elholm, Frode L. Jahnsen, George E. Georges, Tobias Gedde-Dahl
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e24026- (2024)
Background & aims: Durable remissions of Crohn's Disease (CD) have followed myeloablative conditioning therapy and allogeneic marrow transplantation. For patients with treatment-refractory disease, we used reduced-intensity conditioning to minimize t
Externí odkaz:
https://doaj.org/article/bdeefb3eb92c4e6ab5819534e0b1348b
Autor:
Arnon Nagler, Jacques‐Emmanuel Galimard, Myriam Labopin, Didier Blaise, William Arcese, Silvia Maria Trisolini, Depei Wu, Arnaud Pigneux, Gwendolyn Van Gorkom, Marie‐Thérèse Rubio, Tobias Gedde‐Dahl, Anne Huynh, Francesco Lanza, Norbert‐Claude Gorin, Mohamad Mohty
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1482-1491 (2023)
Abstract Background Achieving complete remission (CR) is the main goal in AML treatment and a prerequisite for successful autologous stem cell transplantation (ACT). Methods Comparing results of peripheral blood ACT in patients with AML in CR1 attain
Externí odkaz:
https://doaj.org/article/4cd378cf9437447297a9c43b0459cddb
Autor:
Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Julie Røkke Osen, Viktoriia Chaban, Katrine Persgård Lund, Lisa Tietze, Trung The Tran, Fridtjof Lund-Johansen, Hassen Kared, Andreas Lind, John Torgils Vaage, Richard Stratford, Simen Tennøe, Brandon Malone, Trevor Clancy, Anders Eivind Leren Myhre, Tobias Gedde-Dahl, Ludvig André Munthe
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Poor overall survival of hematopoietic stem cell transplantation (HSCT) recipients who developed COVID-19 underlies the importance of SARS-CoV-2 vaccination. Previous studies of vaccine efficacy have reported weak humoral responses but conflicting re
Externí odkaz:
https://doaj.org/article/12d1aa38907c4c938042e4acb5e9bb70
Autor:
Jani Huuhtanen, Mette Ilander, Bhagwan Yadav, Olli M.J. Dufva, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Ulla Olsson-Strömberg, Jesper Stentoft, Johan Richter, Perttu Koskenvesa, Martin Höglund, Stina Söderlund, Arta Dreimane, Kimmo Porkka, Tobias Gedde-Dahl, Björn T. Gjertsen, Leif Stenke, Kristina Myhr-Eriksson, Berit Markevärn, Anna Lübking, Andreja Dimitrijevic, Lene Udby, Ole Weis Bjerrum, Henrik Hjorth-Hansen, Satu Mustjoki
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 17 (2022)
In chronic myeloid leukemia (CML), combination therapies with tyrosine kinase inhibitors (TKIs) aim to improve the achievement of deep molecular remission that would allow therapy discontinuation. IFN-α is one promising candidate, as it has long-las
Externí odkaz:
https://doaj.org/article/41296f647a1141389dad7968d6690e57